Oxitone Medical Overview
Oxitone Medical is the developer of the Oxitone 1000M pulse oximeter, an FDA-cleared medical device designed to continuously monitor and automatically flag critical medical issues in patients with severe chronic diseases, enabling them to get immediate help in the easiest and most straightforward way. The devices sensors are placed around the patients ulnar bone at the wrist, where they deliver a reading every second to the cloud. The basic measurements include SpO2, pulse rate, HRV, motion, and skin temperature. The device also delivers actionable insights such as hypoxia index, apnea index, activity index, sleep efficiency, and physiological stress. Oxitone Medical focuses on patients with acute respiratory failure a common complication of COVID-19 as well as physiological stress and sleep disorders.
Cumulative Funding Raised Over Time ($)
$2.0MJan 2018
$2.9MMar 2013
$7.9MSep 2014
Latest News
growth-positive
Ascom UMS Selected Oxitone Medical as a Wearable Solution for Continuous Remote Monitoring of COVID-19 Patients
Ascom UMS, an Italian telecommunication solutions provider, has selected Oxitone Medical as a wearable solution for continuous remote monitoring of COVID-19 patients. Ascoms clients are implementing the Digistat® Wearables solution with the Oxitone 1000M device for remote continuous monitoring. This integration enhances patient safety and optimizes the workflow of healthcare professionals. Oxitones wrist-sensor pulse oximetry monitor provides easy and comfortable continuous and prolonged measurements. The collaboration with Oxitone validates the value of their wearable medical solution and marks a major step in their strategic expansion into Europe.
Customers
growth-positive
OXITONE, the World's First FDA-Cleared Wrist Sensor, Pulse Oximeter Monitoring Device to Detect the Early Symptoms of COVID-19 and Other Chronic Diseases
betweenMD has announced a partnership with Oxitone, the makers of the worlds first FDA-cleared risk monitoring device. Oxitone has developed a wearable monitoring device for in-home use for patients with respiratory failure, specifically for prolonged monitoring of those at risk for COVID-19. The partnership aims to scale up the customer base across the US and develop advanced monitoring solutions. betweenMD is the authorized reseller for Oxitone 1000M in the US and will offer the state-of-the-art health-monitoring platform to better lives and society at large. The deployment of Oxitone solutions is expected to reach at least 10,000 units in the US within the next year.
Partners
growth-positive
StartUp Health's Tech Product Watch: Oxitone 1000M
Israeli medtech company Oxitone has developed the worlds first FDA-cleared, hospital-grade pulse oximeter worn on the wrist. The device continuously measures blood oxygen levels and provides insights into potential medical conditions. Oxitones technology enables readings from the wrist using back scattered light and forward scattered light measurement modes. The Oxitone 1000M is designed for continuous supervision of patients with cardiopulmonary diseases and allows for remote support and early medical intervention. The companys growth prospects are positive.
CustomersPartners
growth-positive
FDA clears Oxitone's wrist-worn pulse ox for remote patient monitoring
Oxitone Medical, based in Ashkelon, Israel, has received FDA clearance for its wristworn pulse oximeter, the Oxitone 1000. The device can measure SpO2 and pulse rate with the same accuracy as traditional fingertip pulse oximeters. Oxitone is targeting the clinical market and aims to improve patient adherence to monitoring by offering a more comfortable and convenient device. The company plans to integrate the wristworn pulse oximeter with its patient management and monitoring digital health platform, which includes a companion mobile application and cloud supervisors portal. Oxitone believes that its solution will provide value for patients and providers and lead to significant cost savings.
CustomersPartners
Growth-Positive
25 brilliant Israeli tech companies to watch in 2017
The article discusses the innovative technologies and inventions that Israeli companies are expected to introduce to the market in 2017. These include augmented reality (AR) headsets for outdoor activities, 3D remote sensing solutions for autonomous cars, unmanned drone systems for industrial facilities, wearable devices for health monitoring, eco-friendly technologies, and financial technology solutions. The article also mentions several partnerships and investments involving these companies.
CustomersPartnersInvestmentAcquisition
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $9.2M |
| Last funding | $2M |
| Stage | Mature |
| Rounds | 4 |
| Investors | 4 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | www.oxitone.com |
| Careers | Careers page |
| App Store | App Store |
Locations
Atir Yeda Street 17, Kefar Sava, Israel
20 Church Street, Hartford, CT 06103, USA
Photos & Videos
3 item(s)
Oxitone Medical Business
Business models
B2B, B2B2C
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesMedical MonitorsTarget Customer
Healthcare & Life SciencesHealthcareInsurance CompaniesPatientsProvidersConsumersDemographics & FamilySeniorsCore Technology
Semiconductors & ElectronicsWearablesArtificial IntelligenceMachine LearningSensingTags (26)
non-invasivesensorswearableseniorsreal-timeremote-monitoringphysiological-parameterschronic-diseasepreventioniotdigital-healthcaremobile-applicationsartificial-intelligenceartificial-intelligencedata-analyticsmhealthtelehealthmachine-learningchronic-patientssaasvital-signspharma-companieshealthcare-providersmedical-devicesoptronicsmedical-technologiesGeographic Markets
North AmericaUnited StatesEuropeItalyOxitone Medical Financials
$9.2M
Total funding
Undisclosed
Capital raised
$2M
Last funding
Mature
Funding stage
4
Total rounds
4
Investors
Cumulative Funding Raised Over Time ($)
$2.0MJan 2018
$2.9MMar 2013
$7.9MSep 2014
Private Equity Funding
Convertible Debt
Jan 2018
$2M
A Round
Sep 2014
$5M
Telcom Ventures
Seed
Mar 2013
$900K
GE Ventures, Gefen Biomed Investments, StartUp Health
Non-Equity Funding
GrantEvent
Jan 2015
$1.3M
Israel Innovation Authority
Oxitone Medical Lifecycle
Cumulative Funding Raised Over Time
$2.0MJan 2018
$2.9MMar 2013
$7.9MSep 2014
All Events
Convertible Debt
Jan 2018
$2M
A Round
Sep 2014
$5M
Telcom Ventures
Seed
Mar 2013
$900K
GE Ventures, Gefen Biomed Investments, StartUp Health
GrantEvent
Jan 2015
$1.3M
Israel Innovation Authority
Oxitone Medical News
7 articles
growth-positive
Ascom UMS Selected Oxitone Medical as a Wearable Solution for Continuous Remote Monitoring of COVID-19 Patients
Ascom UMS, an Italian telecommunication solutions provider, has selected Oxitone Medical as a wearable solution for continuous remote monitoring of COVID-19 patients. Ascoms clients are implementing the Digistat® Wearables solution with the Oxitone 1000M device for remote continuous monitoring. This integration enhances patient safety and optimizes the workflow of healthcare professionals. Oxitones wrist-sensor pulse oximetry monitor provides easy and comfortable continuous and prolonged measurements. The collaboration with Oxitone validates the value of their wearable medical solution and marks a major step in their strategic expansion into Europe.
Customers
growth-positive
OXITONE, the World's First FDA-Cleared Wrist Sensor, Pulse Oximeter Monitoring Device to Detect the Early Symptoms of COVID-19 and Other Chronic Diseases
betweenMD has announced a partnership with Oxitone, the makers of the worlds first FDA-cleared risk monitoring device. Oxitone has developed a wearable monitoring device for in-home use for patients with respiratory failure, specifically for prolonged monitoring of those at risk for COVID-19. The partnership aims to scale up the customer base across the US and develop advanced monitoring solutions. betweenMD is the authorized reseller for Oxitone 1000M in the US and will offer the state-of-the-art health-monitoring platform to better lives and society at large. The deployment of Oxitone solutions is expected to reach at least 10,000 units in the US within the next year.
Partners
growth-positive
StartUp Health's Tech Product Watch: Oxitone 1000M
Israeli medtech company Oxitone has developed the worlds first FDA-cleared, hospital-grade pulse oximeter worn on the wrist. The device continuously measures blood oxygen levels and provides insights into potential medical conditions. Oxitones technology enables readings from the wrist using back scattered light and forward scattered light measurement modes. The Oxitone 1000M is designed for continuous supervision of patients with cardiopulmonary diseases and allows for remote support and early medical intervention. The companys growth prospects are positive.
CustomersPartners
growth-positive
FDA clears Oxitone's wrist-worn pulse ox for remote patient monitoring
Oxitone Medical, based in Ashkelon, Israel, has received FDA clearance for its wristworn pulse oximeter, the Oxitone 1000. The device can measure SpO2 and pulse rate with the same accuracy as traditional fingertip pulse oximeters. Oxitone is targeting the clinical market and aims to improve patient adherence to monitoring by offering a more comfortable and convenient device. The company plans to integrate the wristworn pulse oximeter with its patient management and monitoring digital health platform, which includes a companion mobile application and cloud supervisors portal. Oxitone believes that its solution will provide value for patients and providers and lead to significant cost savings.
CustomersPartners
Growth-Positive
25 brilliant Israeli tech companies to watch in 2017
The article discusses the innovative technologies and inventions that Israeli companies are expected to introduce to the market in 2017. These include augmented reality (AR) headsets for outdoor activities, 3D remote sensing solutions for autonomous cars, unmanned drone systems for industrial facilities, wearable devices for health monitoring, eco-friendly technologies, and financial technology solutions. The article also mentions several partnerships and investments involving these companies.
CustomersPartnersInvestmentAcquisition
growth-positive
A Growing Role in Health Care for Smartwatches (Published 2014)
The article discusses the emergence of new brands of watches that are focused on health and fitness. These watches go beyond simply telling time and offer features such as fitness tracking and health monitoring. The Basis watch company is mentioned as one of the brands leading this trend. The article highlights the potential of these watches in aiding the treatment of the sick and managing chronic conditions. It also mentions other brands such as Oxitone, Philip Stein, and Pebble that offer health-related features in their watches. The article suggests that wearable technology, particularly in the form of watches, has the potential to revolutionize healthcare and reduce healthcare costs.
CustomersPartners
growth-positive
A 'watch' that stops unnecessary heart attack deaths
Israeli entrepreneur Leon Eisen has developed the Oxitone device, a wearable watch-like mobile device that continuously monitors heart rate and oxygen levels in the blood. The device sends alerts when heart rates change and oxygen levels drop, providing an early clinical response for cardiac or pulmonary attacks. Oxitone was chosen to be part of GE Healthcares Start-Up Health Academy Entrepreneurship Program. Eisen is seeking a $3 million investment to start clinical trials in Israel and the UK. The device is estimated to cost $200, plus a monthly service fee.
Investment
Oxitone Medical Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 10 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 18 classification IDs that could be used for matching.
Oxitone Medical Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 93/100 |
| Missing | markets, not claimed |
| BI Verification | Sharon Shapira |
| Registrar ID | 514457118 |
| Crunchbase | oxitone |
| Phone | +97298346731 |
| Creator | Sophie Pollock |
| Creator email | pollos@blair.edu |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-11-25T00:00:00.000Z |
| Created | 2014-06-25T00:00:00.000Z |
| Claimed | Yes |